TETRAPHASE PHARMACEUTICALS I - COM (TTPH)

CUSIP: 88165N105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
21,705,374
Share change
-1,312,832
Total reported value
$77,484,208
Put/Call ratio
55%
Price per share
$3.57
Number of holders
87
Value change
-$3,897,674
Number of buys
40
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 88165N105?
CUSIP 88165N105 identifies TTPH - TETRAPHASE PHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q2 2018

As of 30 Jun 2018, TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,705,374 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, BAKER BROS. ADVISORS LP, Tekla Capital Management LLC, Man Group plc, PANAGORA ASSET MANAGEMENT INC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 87 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.